Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 22;13:13097–13109. doi: 10.2147/OTT.S286627

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Li et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

The high expression of SOX4 in ESCC and the association between SOX4 and MIR205HG. (A) The expression profile of SOX4 in the pan-cancer analysis. (B and C) GEPIA and Oncomine analysis showed SOX4 was significantly elevated in ESCC. (D) The disease-free survival analysis of SOX4 in ESCC. (E) The ROC analysis of SOX4 in ESCC. (F) SOX4 expression was remarkably reduced after knocking down MIR205HG. (G) The miR −214 inhibitor increased SOX4 expression in EC109 cell. (H) The SOX4 protein was reduced after MIR205HG silence in EC109 cell. *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001.